Oxford BioMedica Share Price (OXB)

4.95 +0.40 (+8.79%) delayed: 5:53PM GMT
Bid price 4.85 Open price 4.55
Ask price 4.95 Prev close 4.95
High price 4.97 Spread 2.02%
Low price 4.57 Volume 4,116,164

Register now for FREE live Oxford BioMedica share prices, Oxford BioMedica stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Oxford BioMedica Level 2 Data, indepth research tools and investor commentary for Oxford BioMedica (OXB) and other London Stock Exchange equities.

Oxford BioMedica Share Price Chart

Advanced Charts >>

Register now for FREE Oxford BioMedica share price charts

Oxford BioMedica Share Price Information

Name Oxford BioMedica Epic OXB
Sector Pharmaceuticals & Biotechnology ISIN GB0006648157
Activites Oxford BioMedica plc is a biopharmaceutical company developing innovative gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs. The Company's technology platform includes a highly efficient LentiVector gene delivery system, which has specific advantages for targeting diseases of the central nervous system and the eye; and a unique tumour antigen (5T4), which is an ideal target for anti-cancer therapy. Through in-house and collaborative research, Oxford BioMedica has a broad pipeline with current partners and licensees including Sanofi, Pfizer, Novartis, GlaxoSmithKline, MolMed, Sigma-Aldrich, Biogen Idec, Emergent BioSolutions, ImaginAb and Immune Design Corp. Index n/a

Oxford BioMedica Key Numbers

Latest Share Price (p) 4.95 Net Gearing (%) 18.89
Market Capitalisation (£m) 116.73 Gross Gearing (%) 34.79
Shares in issue (m) 2,565.39 Debt Ratio 5.64
P/E Ratio -5.76 Debt-to-Equity Ratio 0.11
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.53
Dividend Yield (%) 0.00 Price to book value 13.12
Dividend cover (x) 0.00 ROCE -1.12
Earning per share (p) -0.79 EPS Growth (%) -3.95
52 week high / low 4.63 / 1.83 DPS Growth (%) n/a

Oxford BioMedica Director Deals

Dec.Date Type Director Pos No. of Shares
26/11/2014 BUY Paul Blake ED 215,000
14/10/2014 BUY Paul Blake ED 243,902
01/07/2014 BUY Paul Blake ED 285,000
22/11/2013 BUY Nicholas Rodgers CH 208,000
19/09/2013 BUY Andrew Heath NED 100,000

More Oxford BioMedica Director Deals >>

Oxford BioMedica Company News

09:20 26/11/2014

Director Deals - Oxford BioMedica PLC (OXB)

Paul Blake, Executive Director, bought 215,000 shares in the company on the 25th November 2014 at a price of 4.60p. The Director now holds 2,526,999 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com

07:00 26/11/2014

Director Dealings

/* */ RNS Number : 9978X Oxford Biomedica PLC 26 November 2014                Oxford BioMedica plc Director's Share Purchase     Oxford, UK - 26 November 2014: Oxford BioMedica plc...

07:17 03/11/2014

FLASH: Oxford Biomedica issues interim management statement

Story provided by StockMarketWire.com

More Oxford BioMedica Company News >>

Register now for FREE Oxford BioMedica company news

Oxford BioMedica Share Price Discussions

07 hours ago

CANCER drug co. Oxford Biomedica charts (OXB)

OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles. So here is a new title This one has got the charts at the top again & has a link to the old one....

more than 1 year ago

OXFORD BIOMEDICA TO REACH NEW HIGH`S THIS WEEK...? (OXB)

Very strong rumours of a further predator around. CAT,WYEYH,JOHNSON&JOHNSON,MERCK to name a few.............could be an exciting week ...!

more than 1 year ago

OXFORD BIOMEDICA TO REACH NEW HIGH`S THIS WEEK...? (OXB)

Very strong rumours of a further predator.........CAT,JOHNSON&JOHNSON,WYETH,MERCK to name a few. Could be an interesting week..!

Register now for FREE Oxford BioMedica share price discussions